Pharmacologic Therapy of Ocular Disease

CHF 332.75
Auf Lager
SKU
F0VOMH0VDMO
Stock 1 Verfügbar
Geliefert zwischen Di., 24.02.2026 und Mi., 25.02.2026

Details

There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function.

Current review of the basic principles of ocular pharmacology, pharmacokinetics, and drug delivery including novel approaches to delivering compounds to the eye like sustained-release implants, cell therapy, and gene therapy Review of existing and future therapies for ocular diseases from the eye lids to the optic nerve Discussion of potential adverse effects of pharmacologic treatments and limitationof side effects in the treatment of ocular disease Includes supplementary material: sn.pub/extras Includes supplementary material: sn.pub/extras

Inhalt

General Principles: Principles of Ocular Pharmacology.- Ocular Pharmacokinetics.- Ocular Drug Delivery.- Anterior Segment and Tear Film: Tear Film-dry eye.- Conjunctiva-allergic conjunctivitis, infectious conjunctivitis, conjunctival hyperemia .- Cornea-Keratitis, antibiotics, antifungals, anti-virals, anti-inflammatory agents including corticosteroids and NSAIDS.- Cornea-Keratoconus and other corneal disease, Pharmacologic cross-linking and future therapy.- Lens-management of cataract surgery, cataract prevention, floppy iris syndrome.- Trabecular Meshwork and Uvea: Glaucoma-Intraocular Pressure Reduction.- Glaucoma-Neuroprotection .- Uveitis.- Posterior Segment and Optic Nerve: Retina Anti-angiogenesis, AMD, Myopia, DME.- Retina Anti-inflammatory therapy, corticosteroids, anti-complement, AMD, DME.- Atrophic AMD.- Hereditary Retinal Disease .- Optic Nerve.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783319582887
    • Editor Dimitri T. Azar, Scott M. Whitcup
    • Sprache Englisch
    • Auflage 1st edition 2017
    • Größe H241mm x B160mm x T26mm
    • Jahr 2017
    • EAN 9783319582887
    • Format Fester Einband
    • ISBN 3319582887
    • Veröffentlichung 16.06.2017
    • Titel Pharmacologic Therapy of Ocular Disease
    • Untertitel Handbook of Experimental Pharmacology 242
    • Gewicht 843g
    • Herausgeber Springer International Publishing
    • Anzahl Seiten 404
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38